Vertanical Secures FDA Breakthrough Designation for Cannabis-Based Pain Drug
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
24 results for “rcts”
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
A comprehensive guide on how to read and interpret cannabis research.
A balanced CBD and THC cannabis flower was found to be more effective for treating acute migraine symptoms than a placebo.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week.
A new review has found ‘consistent evidence’ that cannabis improves sexual function in women.
In a special edition of the Business of Cannabis Podcast, we go from anecdote to evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf.
Medical cannabis may improve quality of life for people living with obsessive compulsive disorder (OCD).
The Advisory Council on the Misuse of Drugs (ACMD) will carry out a formal review of the regulatory framework around cannabis-based medicinal products.
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could it help bridge the […]
Cannabis clinics can play a crucial role in changing this landscape by setting high professional standards and ensuring patients receive the same level of care as with any other medical treatment.
Almost 400 families were found to be sourcing illegal cannabis products having been unable to get a prescription on the NHS.
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major […]
Researchers at the University of Edinburgh say CBD is a “promising therapeutic agent” due to its varying effects on the body.
Six years on from the legalisation of medical cannabis in the UK, new figures reveal lack of NHS prescribing.
Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy.
The latest UK research points to the potential benefits of medical cannabis in two long-term conditions.
Patients showed improvements in sleep, anxiety and overall quality of life.
As we mark the fifth anniversary of the legalisation of medical cannabis in the UK, we look back at the last five years.